#None #Medtronic #Hugo RAS #LigaSure

Medtronic's Newest FDA-Cleared Instrument Revolutionizes Robotic Surgery

Medtronic, a leading global player in healthcare technology, recently announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the LigaSure™ RAS Maryland jaw device, designed to work with its innovative Hugo™ robotic-assisted surgery (RAS) system. This pivotal approval marks a significant expansion of the instruments available in the Hugo system, integrating Medtronic's proven vessel-sealing technology into robotic-assisted surgical procedures.

For over two decades, LigaSure™ technology has been trusted by surgeons globally, having been utilized in more than 45 million surgical procedures across 65 countries. The introduction of this advanced instrument aims to meet the growing expectations of surgeons who are progressively adopting robotic-assisted surgery. They seek the same reliable energy devices they rely on in traditional open and laparoscopic surgeries.

According to Dr. Matthew Kroh, Chief Medical Officer of Medtronic’s Surgical business and a practicing surgeon, the LigaSure RAS Maryland instrument provides surgeons with the confidence and control necessary for managing complex surgical procedures. It empowers them to harness the familiar performance standards of LigaSure™ across both traditional and robotic frameworks.

The FDA-approved Hugo RAS system is already in use for urological surgeries in the U.S. and is being adopted by a growing number of prestigious health systems and hospitals across the nation. Medtronic has ambitious plans to broaden the applications of Hugo to include an extensive range of soft-tissue surgical procedures such as general and gynecological surgeries in the near future.

The LigaSure™ RAS Maryland instrument is engineered to perform a dual function of sealing and cutting vessels, fibrous tissues, and lymphatics that are up to 7 mm in diameter. The device can seal these vessels in roughly 2 seconds, all while minimizing thermal damage to surrounding tissues—a crucial aspect in maintaining patient safety and improving surgical outcomes.

As the first robotic-driven LigaSure™ instrument, it reflects Medtronic's commitment to supporting surgeons' diverse needs across various surgical modalities, be it open, laparoscopic, or robotic-assisted surgery. By providing versatile surgical solutions, Medtronic seeks to enhance the safety and efficacy of surgical programs across healthcare facilities.

The introduction of the LigaSure™ RAS Maryland instrument parallels Medtronic’s broader mission to alleviate pain, restore health, and extend life through continuous innovation in medical technology. With a passionate team of over 95,000 individuals operating in more than 150 countries, the company's dedication to addressing the most pressing health challenges is apparent.

In the wake of the global transformation towards robotic-assisted surgeries, this latest advancement stands to positively impact patient care and surgical efficiency. Surgeons will now have the advantage of employing a trusted vessel-sealing technology in robotic-assisted procedures, likely leading to improved surgical outcomes and patient recovery times.

As Medtronic continues to enhance its product offerings and expand the capabilities of its technologies, the healthcare landscape is poised to advance significantly towards more precise and effective surgical interventions. To explore more about the LigaSure™ RAS Maryland instrument, please visit Medtronic's official websiteLigaSureOnHugo.

About Medtronic

Medtronic plc, headquartered in Galway, Ireland, represents the forefront of global healthcare technology. Its mission focuses on combating critical health issues, with a robust product portfolio that treats over 70 health conditions, including cardiac devices, surgical robotics, and insulin pumps. As a thought leader, Medtronic strives to push the boundaries of technology to transform lives worldwide.

As the demand for enhanced and reliable surgical solutions continues to grow, Medtronic remains committed to its vision of improving healthcare outcomes through innovative solutions designed to cater to patients’ unique needs. The approval of the LigaSure™ RAS Maryland instrument is just another example of how Medtronic is engineering the extraordinary in healthcare.